Texas Administrative Code (Last Updated: March 27,2024) |
TITLE 26. HEALTH AND HUMAN SERVICES |
PART 1. HEALTH AND HUMAN SERVICES COMMISSION |
CHAPTER 261. INTERMEDIATE CARE FACILITIES FOR INDIVIDUALS WITH AN INTELLECTUAL DISABILITY OR RELATED CONDITIONS (ICF/IID) PROGRAM--CONTRACTING |
SUBCHAPTER J. SURROGATE DECISION-MAKING |
SECTION 261.281. Purpose
Latest version.
-
(a) The purpose of this division is to describe a process by which certain treatment decisions are made by an IDT, surrogate decision-maker, or surrogate consent committee on behalf of an individual who lacks the capacity to make an informed decision about the proposed treatment, medication, or procedure and has no LAR. A treatment decision involves giving or denying consent for a treatment, medication, or procedure for an individual. (b) The process described in this division applies only to a treatment decision for an individual regarding: (1) the use of a psychoactive medication; (2) a highly restrictive procedure; (3) major medical treatment; (4) major dental treatment; (5) a risk to individual protection and rights; or (6) the release of records related to the individual's condition or treatment to facilitate the treatment to which a surrogate decision-maker or surrogate consent committee has consented. (c) This division does not apply to a decision for an individual regarding: (1) experimental research; (2) sterilization: (3) management of funds; (4) electroconvulsive treatment; or (5) abortion. Source Note: The provisions of this §261.281 adopted to be effective July 1, 2007, 32 TexReg 3856; transferred effective October 1, 2020, as published in the Texas Register August 28, 2020, 45 TexReg 6127